Carotid Doppler ultrasound findings in patients with left ventricular assist devices

Ultrasound Quarterly

Volumn 26, Issue 4, 2010, Pages 255-261

  Cervini, Patrick ^a   Park, Soon J ^a   Shah, Dipesh K ^a   Penev, Irina E ^a   Lewis, Bradley D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carotid artery; Common femoral artery; Left ventricular assist device; Vertebral artery

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CAROTID ARTERY DOPPLER SONOGRAPHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DOPPLER ECHOGRAPHY; HEART ASSIST DEVICE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VELOCITY; WAVEFORM;

ADULT; AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER;

EID: 78650480706     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: 10.1097/RUQ.0b013e3181fe2a97     Document Type: Article

References (15)

1. Frazier OH, Delgado RM III, Kar B, et al. First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: A case report. Tex Heart Inst J. 2004;31:157-159.
2. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
3. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
4. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186-1195.
5. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222: 327-336.
6. Baldwin JT, Robbins RC. Executive summary for the National Heart, Lung, and Blood Institute Working Group on next generation ventricular assist devices for destination therapy. Semin Thorac Cardiovasc Surg. 2005;17:369-371.
7. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg. 2007;133:1573-1580.
8. Pagani FD. Continuous-flow rotary left ventricular assist devices with B3rd generation[ design. Semin Thorac Cardiovasc Surg. 2008;20:255-263.
9. Frazier OH, Gemmato C, Myers TJ, et al. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34:275-281.
10. Carr CM, Jacob J, Park SJ, et al. CT of left ventricular assist devices. Radiographics. 2010;30:429-444.
11. Struber M, Sander K, Lahpor J, et al. HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg. 2008;34:289-294.
12. Lietz K, Brown K, Ali SS, et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg. 2009;137:1012-1 019.
13. Frazier OH, Myers TJ, Westaby S, et al. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: Physiologic implications and their relationship to patient selection. Ann Thorac Surg. 2004;77:133-142.
14. Lazar RM, Shapiro PA, Jaski BE, et al. Neurological events during long-term mechanical circulatory support for heart failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004;109:2423-2427.
15. Mussivand T. Neurological dysfunction associated with mechanical circulatory support: Complications that still need attention. Artif Organs. 2008;32:831-834.